COX4I1 and hematopoietic and lymphoid system neoplasm: Further, CRISPR targeting of these COX4I1‐regulated Complex IV members (such as COX5A, COX6B1, etc.)also exhibits a selective impact on blood cancer cells (Figure S6, Supporting Information), emphasizing a unique addiction of leukemia cells to the intact functional Complex IV.